Saillant Therapeutics

📍 Nijmegen, Netherlands🗓 Founded 2018👥 4 employees💰 Last funded Feb 2023
Biotechnology Research🌐 saillanttherapeutics.nl
Website LinkedIn
An innovative biotechnology start-up that develops promising small molecule-based therapies against acute ischemic stroke, heart failure (HF) and Alzheimer’s disease.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Saillant Therapeutics?
Saillant Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Saillant Therapeutics last raise funding?
The most recent investment in Saillant Therapeutics recorded on gritt.io was in February 2023.
When was Saillant Therapeutics founded?
Saillant Therapeutics was founded in 2018.
What industry is Saillant Therapeutics in?
Saillant Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Saillant Therapeutics based?
Saillant Therapeutics is headquartered in Nijmegen, Netherlands.